TAP-patients With Robotic Assisted Lap Prostatectomy

Completed · Phase 4

Conditions studied: Postsurgical Pain, Analgesia, Prostatectomy

In brief

The purpose of the study is to assess the safety and efficacy of EXPAREL when administered via infiltration into the transversus abdominis plane (TAP) to prolonged postsurgical analgesia in men undergoing robot-assisted laparoscopic prostatectomy.

Key facts

Study ID
NCT01582477
Run by
Pacira Pharmaceuticals, Inc
People needed
24
Starts
2012-03-01
Expected to finish
2012-07-01
Last updated by the study team
2021-06-14

Who can join

Age: 18 and older, up to 75. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.